Alcon Call Center for Trial Locations
Fort Worth, Texas, 76134, United States
NCT Number: NCT00772707
The purpose of this study was to demonstrate that current successful fulltime daily wear soft contact lens wearers using competitive multi-purpose solutions will note improved comfort when using OPTI-FREE RepleniSH®.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Fort Worth, Texas, 76134, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
OPTI-FREE RepleniSH® used according to product labeled instructions for cleaning and disinfecting study contact lenses, 30 days.
Other names: OPTI-FREE RepleniSH®
Contact lenses per participant's habitual prescription removed nightly for cleaning and disinfecting.
Time frame: Baseline (Day 0)
Prior to any ocular assessments at the visit, comfort ratings were collected on a questionnaire using 5-point Likert scale, with 1=Strongly Agree, 1=Agree, 3=Neutral, 4=Disagree, 5=Strongly Disagree. The percentage of participants responding with "Strongly Agree" or "Agree" for each question is presented.
Time frame: 30 days
Prior to any ocular assessments at the visit, comfort ratings were collected on a questionnaire using 5-point Likert scale, with 1=Strongly Agree, 1=Agree, 3=Neutral, 4=Disagree, 5=Strongly Disagree. The percentage of participants responding with "Strongly Agree" or "Agree" for each question is presented.
Looking for future studies?
Notify MeAlcon Research
Industry
A 30 Day, Multi-Centered, Open Label Study To Determine Comfort and Overall Contact Lens Wearing Experience Using OPTI-FREE RepleniSH® MPDS as Compared to COMPLETE®MPS Easy Rub™ or ReNu MultiPlus® in Daily Wear Soft Contact Lens Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05320042
Astigmatism, Eye Diseases
Rochester, New York, United States
View Trial DetailsNCT07284966
Astigmatism, Eye Diseases
San Diego, California, United States
View Trial DetailsNCT06817785
Eye Diseases, Myopia
Waterloo, Ontario, Canada
View Trial DetailsNCT07780851
Eye Diseases, Myopia
Singapore
View Trial Details